Varian announces 2-for-1 stock split:
This article was originally published in Clinica
Stockholders of Varian Medical, the developer of integrated cancer therapy systems, are to receive a 100% stock dividend after the company declared a 2-for-1 stock split. The split will increase the number of authorised shares of common stock by 90 million to a total of 189 million. The dividend will be paid on July 30, leaving Varian, of Palo Alto, California, with approximately 136.2 million shares of stock outstanding.